BioCentury
ARTICLE | Company News

GSK, Vanderbilt in obesity deal

February 14, 2013 2:12 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) partnered with Vanderbilt University (Nashville, Tenn.) to discover, develop and commercialize positive allosteric modulators (PAMs) of melanocortin 4 receptor ...